These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7292420)

  • 21. [The advantages and limitations of posology rationalization (author's transl)].
    Sommadossi JP; Aubert C; Cano JP; Rigault JP; Monjanel S
    Therapie; 1980; 35(3):391-3. PubMed ID: 7423431
    [No Abstract]   [Full Text] [Related]  

  • 22. Issues with regulatory pharmacovigilance in East European countries: the industry perspective.
    Hanzl-Dujmović I; Sulić-Milisić Z; Staresinić-Sernhorst I
    Toxicol Lett; 2007 Feb; 168(3):228-35. PubMed ID: 17161561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacovigilance: theoretical and practical aspects].
    Paoletti V; Galeotta G; Mammarella A
    Clin Ter; 1997 Mar; 148(3):67-73. PubMed ID: 9377842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Measurements of plasma drug concentration as a guide in drug therapy].
    Bircher J
    Ther Umsch; 1980 Oct; 37(10):918-23. PubMed ID: 7455956
    [No Abstract]   [Full Text] [Related]  

  • 25. [Unwanted drug interactions. Keeping up pharmacovigilance using databases].
    Schindler B
    Med Monatsschr Pharm; 2008 Apr; 31(4):155-6. PubMed ID: 18497254
    [No Abstract]   [Full Text] [Related]  

  • 26. Dealing with variability: the role of pharmacovigilance.
    Waller PC
    J Pharm Pharmacol; 1994 May; 46 Suppl 1():445-9. PubMed ID: 8064564
    [No Abstract]   [Full Text] [Related]  

  • 27. A model for the future conduct of pharmacovigilance.
    Waller PC; Evans SJ
    Pharmacoepidemiol Drug Saf; 2003; 12(1):17-29. PubMed ID: 12616844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacovigilance in India: how safe are the new drugs? How sure are we?
    Joshi SR; Sapatnekar SM
    J Assoc Physicians India; 2008 Dec; 56():933-4. PubMed ID: 19322970
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacovigilance update].
    Livio F; Buclin T; Biollaz J
    Rev Med Suisse; 2008 Jan; 4(140):150-4. PubMed ID: 18309879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacovigilance: a case of phantom ships and Russian roulette].
    Stricker BH
    Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1258-61. PubMed ID: 12138668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug metabolism in newborn and infants (author's transl)].
    Kadima LN; Lesne M
    J Pharm Belg; 1980; 35(4):301-10. PubMed ID: 7441480
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Lack of drug precipitation in serum and plasma (in vitro).
    Turco SJ; Newman R
    N Engl J Med; 1976 Feb; 294(9):503. PubMed ID: 1675
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmaceutical quality and good manufacturing practices (author's transl)].
    Traisnel
    J Pharm Belg; 1980; 35(3):233-7. PubMed ID: 7400928
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug disposition in cirrhosis (author's transl)].
    Métreau JM
    Gastroenterol Clin Biol; 1981 Nov; 5(11):1052-7. PubMed ID: 7308677
    [No Abstract]   [Full Text] [Related]  

  • 35. [Polymorphism of organic drug substances (author's transl)].
    Bouché R; Draguet-Brughmans M
    J Pharm Belg; 1977; 32(1):23-51. PubMed ID: 864583
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacokinetics, metabolism and pharmacovigilance].
    Benichou C
    Therapie; 1996; 51(5):487-8. PubMed ID: 9138381
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacovigilance: imputability of an adverse reaction].
    Biron P
    Union Med Can; 1986 Jan; 115(1):16-8. PubMed ID: 3952887
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study on the mechanism of drug releases from microcapsules (author's transl)].
    Gu XQ
    Yao Xue Xue Bao; 1980 Nov; 15(11):699-704. PubMed ID: 7257794
    [No Abstract]   [Full Text] [Related]  

  • 39. International Conference on Harmonisation; guidance on E2E Pharmacovigilance Planning; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Apr; 70(62):16827-8. PubMed ID: 15803631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Misuse of drugs: conclusions of the pharmacovigilance workshops at La Baule, France].
    Fermont I;
    Therapie; 2002; 57(3):283-8. PubMed ID: 12422543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.